SynAct Pharma’s Board of Directors has established an Audit Committee that on behalf of the Board will ensure the compliance with the Board’s monitoring responsibility pertaining to internal control, potential internal audit function, risk handling, accounting, and financial reporting. The Audit Committee shall thereby in particular contribute to sound financial reporting and the maintaining of the market’s trust in SynAct Pharma. 

The Audit Committee consists of John Haurum (chair) and Marina Bozilenko.